PREDICTORS OF CDAI TRAJECTORIES IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT: A REAL-WORLD STUDY

被引：0
|
作者：
Bessette, L. [1 ]
Sampalis, J. [2 ,3 ]
Haraoui, B. [4 ]
Rampakakis, E. [3 ,5 ]
Keating, D. [3 ]
Trepanier, M. O. [6 ]
Pope, J. [7 ,8 ,9 ]
机构：
[1] Laval Univ, Ctr Hosp Univ Laval, Montreal, PQ, Canada
[2] McGill Univ, Fac Med, Montreal, PQ, Canada
[3] JSS Med Res Inc, Montreal, PQ, Canada
[4] Inst Rhumatol Montreal, Montreal, PQ, Canada
[5] McGill Univ, Dept Pediat, Montreal, PQ, Canada
[6] Bristol Myers Squibb, Montreal, PQ, Canada
[7] Western Univ, Dept Med, Div Rheumatol, London, ON, Canada
[8] Western Univ, Dept Med, Div Epidemiol, London, ON, Canada
[9] Western Univ, Dept Med, Div Biostat, London, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2024年 / 83卷
关键词：
Observational studies/registry; biological DMARD; Patient Reported Outcome Measures;
D O I：
10.1136/annrheumdis-2024-eular.6058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0634
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CLINICAL AND ULTRASONOGRAPHIC EFFECTIVENESS IN TWO COHORTS OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ABATACEPT: A REAL LIFE STUDY
    Parisi, S.
    Ditto, M. C.
    Scarati, M.
    Priora, M.
    Peroni, C. L.
    Fusaro, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1395 - 1396
  • [22] Abatacept retention and clinical outcomes in Austrian patients with rheumatoid arthritis: real-world data from the 2-year ACTION study
    Peichl, Peter
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Nuesslein, Hubert
    Navarro, Federico
    Elbez, Yedid
    Chartier, Melanie
    Hackl, Roland
    Rauch, Christiane
    Connolly, Sean E.
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2020, 170 (5-6) : 132 - 140
  • [23] Abatacept Retention Rates and Prognostic Factors of Retention in Patients with Rheumatoid Arthritis (RA) Treated in Canada: 2-Year Results from a Real-World Observational Study
    Haraoui, Boulos
    Choquette, Denis
    Bessette, Louis
    Khraishi, Majed
    Maoui, Meryem
    Heitzmann, Julia
    Connolly, Sean
    Alten, Rieke
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 980 - 980
  • [24] SURVIVAL OF ABATACEPT IN RHEUMATOID ARTHRITIS PATIENTS: A REAL-LIFE STUDY
    Molteni, E.
    Ceccarelli, F.
    Castellani, C.
    Giardina, F.
    Alessandri, C.
    Di Franco, M.
    Riccieri, V.
    Spinelli, F. R.
    Scrivo, R.
    Priori, R.
    Conti, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1143 - 1143
  • [25] Clinical and psychological assessment of patients with rheumatoid arthritis and fibromyalgia: a real-world study
    Chao Gao
    Hua Zhong
    Lihong Chen
    Li Wang
    Hong Yao
    Xiaowei Huang
    Yubo Jia
    Chun Li
    Tian Liu
    Clinical Rheumatology, 2022, 41 : 1235 - 1240
  • [26] Real-world effectiveness of tofacitinib in patients with rheumatoid arthritis: a prospective observational study
    Shouval, A.
    Lidar, M.
    Reitblat, T.
    Zisman, D.
    Balbir-Gurman, A.
    Mashiach, T.
    Almog, R.
    Elkayam, O.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (06) : 1378 - 1384
  • [27] Clinical and psychological assessment of patients with rheumatoid arthritis and fibromyalgia: a real-world study
    Gao, Chao
    Zhong, Hua
    Chen, Lihong
    Wang, Li
    Yao, Hong
    Huang, Xiaowei
    Jia, Yubo
    Li, Chun
    Liu, Tian
    CLINICAL RHEUMATOLOGY, 2022, 41 (04) : 1235 - 1240
  • [28] Response trajectories in "real-world" naturalistically treated schizophrenia patients
    Schennach, Rebecca
    Meyer, Sebastian
    Seemueller, Florian
    Jaeger, Markus
    Schmauss, Max
    Laux, Gerd
    Pfeiffer, Herbert
    Naber, Dieter
    Schmidt, Lutz G.
    Gaebel, Wolfgang
    Klosterkoetter, Joachim
    Heuser, Isabella
    Maier, Wolfgang
    Lemke, Matthias R.
    Ruether, Eckart
    Klingberg, Stefan
    Gastpar, Markus
    Musil, Richard
    Moeller, Hans-Juergen
    Riedel, Michael
    SCHIZOPHRENIA RESEARCH, 2012, 139 (1-3) : 218 - 224
  • [29] REAL-WORLD INCIDENCE OF BIOLOGIC DOSE ESCALATION AND IMPACT ON BIOLOGIC COSTS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH INTRAVENOUS AGENTS ABATACEPT, INFLIXIMAB OR TOCILIZUMAB
    Fowler, R.
    McMorrow, D.
    Smith, D.
    Nadkarni, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 558 - 558
  • [30] Predictors of Response in Patients with Psoriatic Arthritis Treated with Anti-TNF in a Real-World Setting
    Sholter, Dalton
    Kelsall, John
    Arendse, Regan
    Avina-Zubieta, Antonio
    Bensen, William
    Zummer, Michel
    Faraawi, Rafat
    Dixit, Sanjay
    Khraishi, Majed
    Fortin, Isabelle
    Sampalis, John
    Psaradellis, Eliofotisti
    Nantel, Francois
    Shawi, May
    Otawa, Susan
    Lehman, Allen
    JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1347 - 1347
12345